feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

India U19 vs Pakistan U19

trending

CUET PG 2026 registration

trending

Perth thunderstorm warning issued

trending

Skoda Slavia Facelift spotted testing

trending

iPhone 16 Pro Price Drop

trending

Bondi Beach shooting: Two suspects

trending

AC Milan face Sassuolo

trending

Venkatesh Iyer IPL auction target

trending

India vs South Africa T20

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Emily's Life Reversed by Common Heartburn Pills

Emily's Life Reversed by Common Heartburn Pills

9 Dec

•

Summary

  • Acid reflux medication caused severe SIBO, leading to extreme weight loss.
  • Commonly prescribed PPIs increase SIBO risk by 4.2% per month.
  • Millions of prescriptions are issued yearly, with many for long-term use.
Emily's Life Reversed by Common Heartburn Pills

A Cambridge woman's life was drastically altered by severe gastrointestinal problems attributed to proton pump inhibitors (PPIs), commonly prescribed for acid reflux. Emily Lyon, 23, suffered extreme diarrhea and lost 3 stone in two months, forcing her to abandon her job and studies. She was diagnosed with small intestinal bacterial overgrowth (SIBO), a condition strongly linked to long-term PPI use.

Studies suggest that prolonged use of PPIs, which reduce stomach acid, can increase the risk of SIBO by over 4% monthly. Despite the potential risks and Emily's struggles, discontinuing the medication often triggers a severe rebound effect of her original heartburn symptoms, leaving her feeling trapped.

While PPIs are among the most frequently prescribed drugs in the UK, experts warn they are often used too broadly and for too long. Alternative treatments and lifestyle changes are recommended for managing reflux, but Emily remains reliant on her current medication while awaiting potential surgery for an underlying hernia.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
SIBO is bacterial overgrowth in the small intestine. PPIs, by reducing stomach acid, may allow bacteria to survive and multiply in the small intestine.
Yes, Emily Lyon experienced significant weight loss due to severe diarrhea caused by SIBO, which is believed to be a side effect of her long-term PPI use.
Long-term PPI use is linked to an increased risk of SIBO and potentially other health issues, with a concerning rebound effect upon discontinuation.

Read more news on

Healthside-arrow

You may also like

Probiotic Hype vs. Science: Are You Wasting Money?

17 hours ago • 3 reads

article image

Eggs Safe: Cancer Doc Debunks Antibiotic Fears

1 day ago • 12 reads

article image

Sick? Your Comfort Foods Might Be Making You Worse

11 Dec • 10 reads

article image

Opioid Use Linked to Dangerous C. diff Infections

10 Dec • 21 reads

Gut Health: Your Secret to Deep Sleep Revealed

5 Dec • 40 reads

article image